| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO2 CACNA2D1 TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 SEC61A1 | 4.61e-08 | 459 | 164 | 18 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA2D1 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A SEC61A1 | 1.61e-07 | 343 | 164 | 15 | GO:0005261 |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 DNHD1 ATP7B DNAH10 ABCA13 SMCHD1 ABCC9 CCT2 CHD7 MORC4 DNAH14 FBH1 G3BP1 KCNJ8 EIF4A1 ERCC6L2 MACF1 ABCC12 ATP1A4 TOP2A | 1.64e-07 | 614 | 164 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D1 ATP7B ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 SEC61A1 | 3.01e-07 | 465 | 164 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | channel activity | ANO2 CACNA2D1 TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 SEC61A1 | 3.39e-07 | 525 | 164 | 18 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO2 CACNA2D1 TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 SEC61A1 | 3.49e-07 | 526 | 164 | 18 | GO:0022803 |
| GeneOntologyMolecularFunction | ribosome binding | 6.55e-07 | 120 | 164 | 9 | GO:0043022 | |
| GeneOntologyMolecularFunction | gated channel activity | ANO2 CACNA2D1 TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A ANO7 | 7.06e-07 | 334 | 164 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO2 CACNA2D1 ATP7B TTYH2 ANO1 ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 ATP1A4 SEC61A1 | 1.12e-06 | 758 | 164 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO2 CACNA2D1 ATP7B ABCA13 SLC2A7 TTYH2 SLC19A3 ANO1 ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 SEC61A2 SLC22A18 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 ABCC12 ATP1A4 SEC61A1 | 1.22e-06 | 1180 | 164 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.01e-06 | 26 | 164 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.16e-06 | 4 | 164 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO2 CACNA2D1 ATP7B TTYH2 ANO1 ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 ATP1A4 SEC61A1 | 2.28e-06 | 793 | 164 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion binding | 4.12e-06 | 14 | 164 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.56e-06 | 193 | 164 | 10 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.47e-06 | 197 | 164 | 10 | GO:0022834 | |
| GeneOntologyMolecularFunction | transporter activity | ANO2 CACNA2D1 ATP7B ABCA13 SLC2A7 TTYH2 SLC19A3 ANO1 ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 SEC61A2 SLC22A18 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 ABCC12 ATP1A4 SEC61A1 | 6.37e-06 | 1289 | 164 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA2D1 ATP7B ANO1 ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 SEC61A1 | 9.30e-06 | 664 | 164 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.60e-06 | 17 | 164 | 4 | GO:0099508 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.07e-05 | 6 | 164 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA2D1 ATP7B ABCC9 GRIA3 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 SEC61A1 | 1.67e-05 | 627 | 164 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP7B DNAH10 ABCA13 SMCHD1 ABCC9 CCT2 CHD7 MORC4 FBH1 G3BP1 EIF4A1 MACF1 ABCC12 ATP1A4 | 1.74e-05 | 441 | 164 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 1.92e-05 | 20 | 164 | 4 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 1.92e-05 | 20 | 164 | 4 | GO:0005229 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 5.30e-05 | 206 | 164 | 9 | GO:0043021 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.70e-05 | 26 | 164 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.69e-05 | 52 | 164 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | N-acetyl-L-aspartate-L-glutamate ligase activity | 6.70e-05 | 2 | 164 | 2 | GO:0072590 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.16e-04 | 31 | 164 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.33e-04 | 182 | 164 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.43e-04 | 184 | 164 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.60e-04 | 140 | 164 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.54e-04 | 151 | 164 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.82e-04 | 109 | 164 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | electron-transferring-flavoprotein dehydrogenase activity | 3.98e-04 | 4 | 164 | 2 | GO:0004174 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.05e-04 | 18 | 164 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.05e-04 | 18 | 164 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HBS1L ATP7B DNAH10 ABCA13 SMCHD1 ABCC9 CCT2 CHD7 MORC4 FBH1 G3BP1 EIF4A1 MACF1 ABCC12 DNM1 ATP1A4 | 6.65e-04 | 775 | 164 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | calcium channel activity | 6.93e-04 | 129 | 164 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 7.53e-04 | 50 | 164 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 8.54e-04 | 23 | 164 | 3 | GO:0017128 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor | 9.84e-04 | 6 | 164 | 2 | GO:0016649 | |
| GeneOntologyMolecularFunction | ATP-activated inward rectifier potassium channel activity | 9.84e-04 | 6 | 164 | 2 | GO:0015272 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 1.16e-03 | 56 | 164 | 4 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 1.23e-03 | 57 | 164 | 4 | GO:0070279 | |
| GeneOntologyMolecularFunction | chloride channel inhibitor activity | 1.37e-03 | 7 | 164 | 2 | GO:0019869 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DAB2IP PDXDC1 FERMT1 OBSCN ACTN3 ITGA2B TENM2 CEMIP2 FASN TJP1 MACF1 TLN2 TAGLN2 | 1.37e-03 | 599 | 164 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HBS1L ATP7B DNAH10 ABCA13 SMCHD1 ABCC9 CCT2 CHD7 MORC4 FBH1 G3BP1 EIF4A1 MACF1 ABCC12 DNM1 ATP1A4 | 1.52e-03 | 839 | 164 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.53e-03 | 28 | 164 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HBS1L ATP7B DNAH10 ABCA13 SMCHD1 ABCC9 CCT2 CHD7 MORC4 FBH1 G3BP1 EIF4A1 MACF1 ABCC12 DNM1 ATP1A4 | 1.54e-03 | 840 | 164 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HBS1L ATP7B DNAH10 ABCA13 SMCHD1 ABCC9 CCT2 CHD7 MORC4 FBH1 G3BP1 EIF4A1 MACF1 ABCC12 DNM1 ATP1A4 | 1.54e-03 | 840 | 164 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.69e-03 | 62 | 164 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 1.88e-03 | 30 | 164 | 3 | GO:0016645 | |
| GeneOntologyMolecularFunction | vitamin binding | 2.17e-03 | 161 | 164 | 6 | GO:0019842 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.48e-03 | 33 | 164 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.76e-03 | 227 | 164 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.92e-03 | 171 | 164 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.97e-03 | 230 | 164 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | ligase activity | 3.19e-03 | 174 | 164 | 6 | GO:0016874 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.44e-03 | 37 | 164 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.56e-03 | 178 | 164 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.00e-03 | 127 | 164 | 5 | GO:0008094 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.16e-08 | 62 | 164 | 8 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.54e-08 | 93 | 164 | 9 | GO:0086003 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | CACNA2D1 ABCC9 ACTN3 RYR1 RYR2 RYR3 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A | 1.75e-07 | 217 | 164 | 12 | GO:0006941 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.69e-07 | 36 | 164 | 6 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.62e-07 | 87 | 164 | 8 | GO:0086001 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.11e-07 | 127 | 164 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.82e-06 | 153 | 164 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | action potential | CACNA2D1 ABCC9 RYR2 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A | 4.93e-06 | 201 | 164 | 10 | GO:0001508 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 7.80e-06 | 167 | 164 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 4.00e-05 | 9 | 164 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 4.74e-05 | 50 | 164 | 5 | GO:0007628 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO2 CACNA2D1 ATP7B TTYH2 ANO1 ABCC9 CHD7 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 ATP1A4 SEC61A1 | 5.89e-05 | 1017 | 164 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO2 CACNA2D1 ATP7B TTYH2 ANO1 ABCC9 GRIA3 CHD7 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 ATP1A4 SEC61A1 | 7.58e-05 | 1115 | 164 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 7.77e-05 | 11 | 164 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to endoplasmic reticulum | 8.23e-05 | 56 | 164 | 5 | GO:0072599 | |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA2D1 ABCC9 ACTN3 RYR1 RYR2 RYR3 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A | 8.89e-05 | 400 | 164 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 1.03e-04 | 31 | 164 | 4 | GO:0045048 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 1.03e-04 | 31 | 164 | 4 | GO:0007635 | |
| GeneOntologyBiologicalProcess | walking behavior | 1.15e-04 | 60 | 164 | 5 | GO:0090659 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.16e-04 | 32 | 164 | 4 | GO:0099505 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA2D1 ABCC9 ACTN3 RYR1 RYR2 RYR3 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A AKAP13 FBXO32 | 1.25e-04 | 547 | 164 | 14 | GO:0003012 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.45e-04 | 63 | 164 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA2D1 SYNE1 ANO1 ABCC9 GRIA3 RYR2 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 | 1.57e-04 | 559 | 164 | 14 | GO:0042391 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RAPSN HTRA2 SYNE1 FERMT1 OBSCN ZDHHC5 SRP72 CCT2 TXNDC12 RYR2 NOMO1 NMD3 TYK2 KAT7 SEC61A2 NOMO2 MACF1 AKAP11 SEC61A1 TNPO3 NOMO3 | 1.58e-04 | 1091 | 164 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.68e-04 | 14 | 164 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | heart process | CACNA2D1 ABCC9 RYR2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A AKAP13 | 1.89e-04 | 309 | 164 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.07e-04 | 37 | 164 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | olfactory behavior | 2.09e-04 | 15 | 164 | 3 | GO:0042048 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO2 CACNA2D1 ATP7B TTYH2 ANO1 ABCC9 GRIA3 CHD7 LETM1 RYR1 RYR2 RYR3 SLC22A18 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ANO7 HSD3B2 ATP1A4 SEC61A1 | 2.26e-04 | 1374 | 164 | 24 | GO:0006811 |
| GeneOntologyBiologicalProcess | nerve development | 2.38e-04 | 109 | 164 | 6 | GO:0021675 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 2.55e-04 | 39 | 164 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.75e-04 | 112 | 164 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | response to ATP | 2.82e-04 | 40 | 164 | 4 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 2.84e-04 | 210 | 164 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 3.33e-04 | 215 | 164 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 3.33e-04 | 215 | 164 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 3.36e-04 | 332 | 164 | 10 | GO:0006520 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA2D1 SPTA1 OBSCN ABCC9 ACTN3 RYR2 CSF1R TJP1 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A TLN2 AKAP13 AKAP11 TAGLN2 | 3.55e-04 | 912 | 164 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | female meiosis chromosome separation | 3.73e-04 | 4 | 164 | 2 | GO:0051309 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 4.08e-04 | 44 | 164 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 4.17e-04 | 121 | 164 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA2D1 ATP7B ANO1 ABCC9 CHD7 LETM1 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 SEC61A1 | 5.20e-04 | 942 | 164 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | post-translational protein targeting to endoplasmic reticulum membrane | 5.91e-04 | 21 | 164 | 3 | GO:0006620 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 5.91e-04 | 21 | 164 | 3 | GO:0071318 | |
| GeneOntologyBiologicalProcess | response to caffeine | 5.91e-04 | 21 | 164 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | heart contraction | 6.53e-04 | 298 | 164 | 9 | GO:0060047 | |
| GeneOntologyBiologicalProcess | protein insertion into membrane | 6.67e-04 | 50 | 164 | 4 | GO:0051205 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 7.10e-04 | 185 | 164 | 7 | GO:0170039 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | ANO2 CACNA2D1 CATSPERD TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A | 8.64e-09 | 378 | 165 | 17 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | CACNA2D1 CATSPERD ABCC9 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A | 4.83e-08 | 235 | 165 | 13 | GO:0034703 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.65e-07 | 17 | 165 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | ANO2 CACNA2D1 CATSPERD TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 | 1.81e-07 | 523 | 165 | 18 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | ANO2 CACNA2D1 CATSPERD TTYH2 ANO1 ABCC9 GRIA3 RYR1 RYR2 RYR3 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 | 3.79e-07 | 550 | 165 | 18 | GO:1990351 |
| GeneOntologyCellularComponent | sarcolemma | 2.80e-06 | 190 | 165 | 10 | GO:0042383 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.94e-06 | 29 | 165 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | myofibril | SYNE1 OBSCN ABCC9 ACTN3 RYR1 RYR2 RYR3 SCN1A KCNJ8 SCN8A FBXO32 | 1.15e-05 | 273 | 165 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | presynaptic membrane | ANO2 CACNA2D1 ANO1 GRIA3 KCNC2 SCN1A KCNJ8 SCN2A SCN8A C1QB DNM1 | 1.32e-05 | 277 | 165 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | membrane protein complex | STX8 ANO2 CACNA2D1 CATSPERD HTRA2 SYNE1 TTYH2 ANO1 ABCC9 GRIA3 ITGA2B RYR1 RYR2 RYR3 TYK2 SEC61A2 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A DNM1 ATP1A4 VAMP8 FLOT1 SEC61A1 | 1.68e-05 | 1498 | 165 | 28 | GO:0098796 |
| GeneOntologyCellularComponent | contractile muscle fiber | SYNE1 OBSCN ABCC9 ACTN3 RYR1 RYR2 RYR3 SCN1A KCNJ8 SCN8A FBXO32 | 2.02e-05 | 290 | 165 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | Z disc | 2.71e-05 | 151 | 165 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 2.98e-05 | 249 | 165 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.92e-05 | 9 | 165 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | I band | 5.33e-05 | 166 | 165 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | synaptic membrane | ANO2 CACNA2D1 RAPSN SYNE1 ANO1 GRIA3 TENM2 PTPRA KCNC2 SCN1A KCNJ8 SCN2A SCN8A C1QB DNM1 | 6.21e-05 | 583 | 165 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.01e-04 | 94 | 165 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.31e-04 | 141 | 165 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA2D1 CATSPERD HTRA2 ABCC9 GRIA3 ITGA2B RYR1 TYK2 KCNC2 SCN1A KCNJ8 SCN2A SCN4A SCN8A SCN9A ATP1A4 FLOT1 | 1.64e-04 | 785 | 165 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.65e-04 | 14 | 165 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | potassium ion-transporting ATPase complex | 1.85e-04 | 3 | 165 | 2 | GO:0031004 | |
| GeneOntologyCellularComponent | intercalated disc | 2.01e-04 | 68 | 165 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.81e-04 | 73 | 165 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | inward rectifying potassium channel | 3.68e-04 | 4 | 165 | 2 | GO:0008282 | |
| GeneOntologyCellularComponent | T-tubule | 4.06e-04 | 79 | 165 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 4.72e-04 | 46 | 165 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | node of Ranvier | 4.99e-04 | 20 | 165 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 6.10e-04 | 5 | 165 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | main axon | 7.01e-04 | 89 | 165 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | translocon complex | 9.10e-04 | 6 | 165 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT16 DNAH10 SYNE1 OBSCN ABCC9 CCT2 ACTN3 DNAH14 RYR1 RYR2 RYR3 KRT23 SCN1A KCNJ8 SCN8A MACF1 AKAP13 CEP295 FBXO32 DNM1 | 1.03e-03 | 1179 | 165 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT16 DNAH10 SYNE1 OBSCN ABCC9 CCT2 ACTN3 DNAH14 RYR1 RYR2 RYR3 KRT23 SCN1A KCNJ8 SCN8A MACF1 AKAP13 CEP295 FBXO32 DNM1 | 1.12e-03 | 1187 | 165 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | rough endoplasmic reticulum membrane | 1.52e-03 | 29 | 165 | 3 | GO:0030867 | |
| GeneOntologyCellularComponent | axon initial segment | 1.52e-03 | 29 | 165 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | junctional membrane complex | 2.15e-03 | 9 | 165 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.67e-03 | 10 | 165 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.67e-03 | 10 | 165 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.39e-03 | 78 | 165 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.55e-03 | 185 | 165 | 6 | GO:0009898 | |
| HumanPheno | Rigidity | UBA5 CACNA2D1 ATP7B HTRA2 SLC19A3 PARS2 RYR1 CSF1R KCNC2 SCN1A SCN2A SCN8A SCN9A DNM1 | 5.74e-07 | 214 | 68 | 14 | HP:0002063 |
| HumanPheno | Impulsivity | UBA5 CACNA2D1 HTRA2 PARS2 KCNC2 SCN1A SCN2A SCN8A SCN9A DEPDC5 DNM1 | 3.39e-06 | 149 | 68 | 11 | HP:0100710 |
| HumanPheno | Unsteady gait | UBA5 CACNA2D1 RAPSN GRIA3 CHD7 PARS2 CSF1R TMTC3 KCNC2 SACS SCN1A SCN8A SMS DNM1 CAPRIN1 AGTPBP1 | 1.22e-05 | 357 | 68 | 16 | HP:0002317 |
| HumanPheno | Status epilepticus | UBA5 CACNA2D1 SLC19A3 GRIA3 PARS2 KCNC2 SCN1A SCN2A SCN8A SCN9A DEPDC5 DNM1 | 1.44e-05 | 207 | 68 | 12 | HP:0002133 |
| HumanPheno | Focal hemiclonic seizure | 1.58e-05 | 25 | 68 | 5 | HP:0006813 | |
| HumanPheno | Hypsarrhythmia | UBA5 GAD1 CACNA2D1 PARS2 KCNC2 SCN1A SCN2A SCN8A DEPDC5 DNM1 CAPRIN1 | 2.70e-05 | 185 | 68 | 11 | HP:0002521 |
| HumanPheno | Status epilepticus with prominent motor symptoms | 3.38e-05 | 29 | 68 | 5 | HP:0032658 | |
| HumanPheno | Focal impaired awareness seizure | 3.74e-05 | 126 | 68 | 9 | HP:0002384 | |
| HumanPheno | EEG with generalized epileptiform discharges | UBA5 GAD1 CACNA2D1 PARS2 KCNC2 SCN1A SCN2A SCN8A SCN9A DEPDC5 DNM1 CAPRIN1 PIGO | 4.42e-05 | 270 | 68 | 13 | HP:0011198 |
| HumanPheno | Dysgenesis of the hippocampus | 4.69e-05 | 16 | 68 | 4 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 4.69e-05 | 16 | 68 | 4 | HP:0011172 | |
| HumanPheno | Hyposmia | 5.69e-05 | 52 | 68 | 6 | HP:0004409 | |
| HumanPheno | EEG with multifocal slow activity | 5.69e-05 | 52 | 68 | 6 | HP:0010844 | |
| HumanPheno | Interictal epileptiform activity | UBA5 GAD1 CACNA2D1 GRIA3 PARS2 KCNC2 SCN1A SCN2A SCN8A SCN9A DEPDC5 DNM1 CAPRIN1 PIGO | 6.01e-05 | 319 | 68 | 14 | HP:0011182 |
| HumanPheno | Atypical absence status epilepticus | 6.07e-05 | 17 | 68 | 4 | HP:0011151 | |
| HumanPheno | Abnormal nervous system electrophysiology | UBA5 GAD1 CACNA2D1 RAPSN ATP7B SYNE1 OBSCN GRIA3 CHD7 DDB2 LETM1 PARS2 RYR1 CSF1R KCNC2 SACS SCN1A SCN2A SCN4A SCN8A SCN9A DEPDC5 SMS DNM1 CAPRIN1 PIGO | 6.90e-05 | 924 | 68 | 26 | HP:0001311 |
| HumanPheno | Interictal EEG abnormality | UBA5 GAD1 CACNA2D1 GRIA3 PARS2 KCNC2 SCN1A SCN2A SCN8A SCN9A DEPDC5 DNM1 CAPRIN1 PIGO | 7.37e-05 | 325 | 68 | 14 | HP:0025373 |
| HumanPheno | Epileptic spasm | UBA5 GAD1 SLC19A3 KCNC2 SCN1A SCN2A SCN8A MACF1 DEPDC5 DNM1 CAPRIN1 | 7.63e-05 | 207 | 68 | 11 | HP:0011097 |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 7.72e-05 | 18 | 68 | 4 | HP:0032860 | |
| HumanPheno | Gait disturbance | UBA5 CACNA2D1 RAPSN ATP7B HTRA2 MARS1 SYNE1 SMCHD1 OBSCN SLC19A3 GRIA3 CHD7 LETM1 PARS2 RYR1 RYR3 CSF1R TMTC3 CYP2R1 KCNC2 SACS SCN1A SCN2A SCN4A SCN8A SCN9A ZFYVE26 SMS DNM1 CAPRIN1 TNPO3 PIGO AGTPBP1 | 8.23e-05 | 1356 | 68 | 33 | HP:0001288 |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.20e-04 | 20 | 68 | 4 | HP:0032671 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.21e-04 | 8 | 68 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.21e-04 | 8 | 68 | 3 | HP:0200048 | |
| HumanPheno | Centrally nucleated skeletal muscle fibers | 1.29e-04 | 60 | 68 | 6 | HP:0003687 | |
| HumanPheno | Focal-onset seizure | CACNA2D1 GRIA3 CSF1R TMTC3 KCNC2 SCN1A SCN2A SCN8A SCN9A MACF1 DEPDC5 SMS DNM1 CAPRIN1 | 1.45e-04 | 346 | 68 | 14 | HP:0007359 |
| HumanPheno | EEG with abnormally slow frequencies | 1.49e-04 | 88 | 68 | 7 | HP:0011203 | |
| HumanPheno | Hyperkalemia | 1.67e-04 | 40 | 68 | 5 | HP:0002153 | |
| HumanPheno | Cuboid-shaped vertebral bodies | 1.76e-04 | 2 | 68 | 2 | HP:0004634 | |
| HumanPheno | Focal clonic seizure | 2.12e-04 | 42 | 68 | 5 | HP:0002266 | |
| HumanPheno | Decreased fetal movement | UBA5 CACNA2D1 RAPSN SYNE1 LETM1 PARS2 RYR1 KCNC2 SCN4A SCN8A DNM1 | 2.28e-04 | 234 | 68 | 11 | HP:0001558 |
| HumanPheno | Reduced tendon reflexes | UBA5 CACNA2D1 RAPSN MARS1 SYNE1 OBSCN GRIA3 DDB2 PARS2 RYR1 KCNC2 SACS SCN4A SCN8A SCN9A DNM1 CAPRIN1 PIGO AGTPBP1 | 3.06e-04 | 617 | 68 | 19 | HP:0001315 |
| HumanPheno | Focal motor seizure | 3.12e-04 | 131 | 68 | 8 | HP:0011153 | |
| HumanPheno | Continuous spike and waves during slow sleep | 3.48e-04 | 11 | 68 | 3 | HP:0031491 | |
| HumanPheno | Limited neck range of motion | 3.48e-04 | 11 | 68 | 3 | HP:0000466 | |
| HumanPheno | Prenatal movement abnormality | UBA5 CACNA2D1 RAPSN SYNE1 LETM1 PARS2 RYR1 KCNC2 SCN4A SCN8A DNM1 | 3.53e-04 | 246 | 68 | 11 | HP:0001557 |
| HumanPheno | Muscle weakness | UBA5 CACNA2D1 RAPSN ATP7B MARS1 SYNE1 SMCHD1 SPTA1 OBSCN SLC19A3 GRIA3 CHD7 PARS2 RYR1 RYR3 CYP2R1 KCNC2 SACS SCN1A SCN2A SCN4A SCN8A ZFYVE26 DNM1 CAPRIN1 TNPO3 AGTPBP1 | 3.66e-04 | 1079 | 68 | 27 | HP:0001324 |
| HumanPheno | Abnormal peripheral nervous system morphology | UBA5 CACNA2D1 RAPSN ATP7B KRT16 HTRA2 MARS1 SYNE1 SMCHD1 OBSCN SLC19A3 GRIA3 CHD7 DDB2 ADCY3 LETM1 PARS2 RYR1 SALL1 CSF1R KCNC2 SACS SCN1A SCN4A SCN8A SCN9A ZFYVE26 DEPDC5 DNM1 CAPRIN1 PIGO AGTPBP1 | 3.82e-04 | 1395 | 68 | 32 | HP:0000759 |
| HumanPheno | Abnormality of central nervous system electrophysiology | UBA5 GAD1 CACNA2D1 RAPSN GRIA3 CHD7 DDB2 LETM1 PARS2 CSF1R KCNC2 SACS SCN1A SCN2A SCN8A SCN9A DEPDC5 SMS DNM1 CAPRIN1 PIGO | 4.03e-04 | 738 | 68 | 21 | HP:0030178 |
| HumanPheno | Status epilepticus without prominent motor symptoms | 4.04e-04 | 27 | 68 | 4 | HP:0031475 | |
| HumanPheno | Simple febrile seizure | 4.04e-04 | 27 | 68 | 4 | HP:0011171 | |
| HumanPheno | Epilepsia partialis continua | 4.59e-04 | 12 | 68 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 4.59e-04 | 12 | 68 | 3 | HP:0032898 | |
| HumanPheno | Focal aware seizure | 4.67e-04 | 28 | 68 | 4 | HP:0002349 | |
| HumanPheno | Symblepharon | 5.22e-04 | 3 | 68 | 2 | HP:0430007 | |
| HumanPheno | Pelvic girdle muscle weakness | 5.34e-04 | 51 | 68 | 5 | HP:0003749 | |
| HumanPheno | Sick sinus syndrome | 5.37e-04 | 29 | 68 | 4 | HP:0011704 | |
| HumanPheno | Gowers sign | 5.46e-04 | 78 | 68 | 6 | HP:0003391 | |
| HumanPheno | Abnormal morphology of the pelvis musculature | 5.84e-04 | 52 | 68 | 5 | HP:0001469 | |
| HumanPheno | Abnormality of the hip-girdle musculature | 5.84e-04 | 52 | 68 | 5 | HP:0001445 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 5.91e-04 | 13 | 68 | 3 | HP:0007058 | |
| HumanPheno | Progressive gait ataxia | 6.13e-04 | 30 | 68 | 4 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 6.13e-04 | 30 | 68 | 4 | HP:0001329 | |
| HumanPheno | EEG abnormality | UBA5 GAD1 CACNA2D1 GRIA3 DDB2 LETM1 PARS2 KCNC2 SCN1A SCN2A SCN8A SCN9A DEPDC5 SMS DNM1 CAPRIN1 PIGO | 6.38e-04 | 548 | 68 | 17 | HP:0002353 |
| HumanPheno | Clonic seizure | 6.69e-04 | 81 | 68 | 6 | HP:0020221 | |
| HumanPheno | Abnormal electrophysiology of sinoatrial node origin | 6.69e-04 | 81 | 68 | 6 | HP:0011702 | |
| HumanPheno | Abnormality of jaw muscles | 6.97e-04 | 31 | 68 | 4 | HP:0045037 | |
| HumanPheno | Incoordination | UBA5 CACNA2D1 ATP7B MARS1 SYNE1 SMCHD1 SPTA1 SLC19A3 CHD7 DDB2 LETM1 PARS2 RYR1 RYR3 COL18A1 CSF1R KCNC2 SACS SCN1A SCN2A SCN4A SCN8A SCN9A ZFYVE26 DNM1 CAPRIN1 PIGO AGTPBP1 | 7.05e-04 | 1184 | 68 | 28 | HP:0002311 |
| HumanPheno | Abnormal muscle fiber-type distribution | 7.62e-04 | 83 | 68 | 6 | HP:0033684 | |
| HumanPheno | Cogwheel rigidity | 7.88e-04 | 32 | 68 | 4 | HP:0002396 | |
| HumanPheno | Pes valgus | 8.24e-04 | 56 | 68 | 5 | HP:0008081 | |
| HumanPheno | Abnormal esophagus morphology | UBA5 CACNA2D1 ATP7B HTRA2 FERMT1 OBSCN SLC19A3 LAMA3 CHD7 F5 LETM1 PARS2 SALL1 CSF1R TMTC3 KCNC2 SACS SCN4A SCN8A SCN9A MACF1 ZFYVE26 CEP295 DNM1 CAPRIN1 TNPO3 | 9.08e-04 | 1078 | 68 | 26 | HP:0002031 |
| HumanPheno | Facial tics | 9.23e-04 | 15 | 68 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 9.23e-04 | 15 | 68 | 3 | HP:0007207 | |
| HumanPheno | Epileptic encephalopathy | 9.48e-04 | 119 | 68 | 7 | HP:0200134 | |
| HumanPheno | Functional abnormality of the gastrointestinal tract | UBA5 CACNA2D1 ATP7B HTRA2 FERMT1 CD109 OBSCN SLC19A3 ANO1 LAMA3 CHD7 ITGA2B F5 LETM1 PARS2 SALL1 CSF1R TMTC3 KCNC2 SACS SCN4A SCN8A SCN9A MACF1 ZFYVE26 DNM1 SEC61A1 CAPRIN1 TNPO3 | 9.71e-04 | 1270 | 68 | 29 | HP:0012719 |
| HumanPheno | Abnormal knee physiology | 9.78e-04 | 87 | 68 | 6 | HP:0034670 | |
| HumanPheno | Anal stenosis | 9.96e-04 | 34 | 68 | 4 | HP:0002025 | |
| HumanPheno | Generalized clonic seizure | 9.96e-04 | 34 | 68 | 4 | HP:0011169 | |
| Domain | Na_channel_asu | 1.05e-08 | 10 | 160 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 1.05e-08 | 10 | 160 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 1.05e-08 | 10 | 160 | 5 | PF06512 | |
| Domain | Na_trans_cytopl | 7.68e-08 | 6 | 160 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 7.68e-08 | 6 | 160 | 4 | IPR024583 | |
| Domain | Ion_trans_dom | 5.97e-07 | 114 | 160 | 9 | IPR005821 | |
| Domain | Ion_trans | 5.97e-07 | 114 | 160 | 9 | PF00520 | |
| Domain | Ryanodine_rcpt | 6.17e-07 | 3 | 160 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 6.17e-07 | 3 | 160 | 3 | IPR009460 | |
| Domain | RyR | 6.17e-07 | 3 | 160 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 6.17e-07 | 3 | 160 | 3 | PF06459 | |
| Domain | Ryan_recept | 6.17e-07 | 3 | 160 | 3 | IPR013333 | |
| Domain | DUF2012 | 2.45e-06 | 4 | 160 | 3 | PF09430 | |
| Domain | DUF2012 | 2.45e-06 | 4 | 160 | 3 | IPR019008 | |
| Domain | Channel_four-helix_dom | 9.10e-06 | 57 | 160 | 6 | IPR027359 | |
| Domain | - | 9.10e-06 | 57 | 160 | 6 | 1.20.120.350 | |
| Domain | CarboxyPept-like_regulatory | 1.13e-05 | 17 | 160 | 4 | IPR008969 | |
| Domain | RIH_assoc-dom | 1.21e-05 | 6 | 160 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.21e-05 | 6 | 160 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.21e-05 | 6 | 160 | 3 | PF08454 | |
| Domain | RIH_dom | 1.21e-05 | 6 | 160 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.21e-05 | 6 | 160 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.21e-05 | 6 | 160 | 3 | IPR015925 | |
| Domain | - | 1.21e-05 | 6 | 160 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.21e-05 | 6 | 160 | 3 | PF01365 | |
| Domain | Anoct_dimer | 2.11e-05 | 7 | 160 | 3 | PF16178 | |
| Domain | Anoct_dimer | 2.11e-05 | 7 | 160 | 3 | IPR032394 | |
| Domain | - | 2.26e-05 | 20 | 160 | 4 | 3.30.565.10 | |
| Domain | HATPase_C | 2.77e-05 | 21 | 160 | 4 | IPR003594 | |
| Domain | Carb-bd-like_fold | 3.35e-05 | 8 | 160 | 3 | IPR013784 | |
| Domain | Spectrin | 4.05e-05 | 23 | 160 | 4 | PF00435 | |
| Domain | IQ | 6.87e-05 | 81 | 160 | 6 | SM00015 | |
| Domain | MIR | 7.08e-05 | 10 | 160 | 3 | PF02815 | |
| Domain | MIR_motif | 7.08e-05 | 10 | 160 | 3 | IPR016093 | |
| Domain | Anoctamin | 7.08e-05 | 10 | 160 | 3 | PF04547 | |
| Domain | Anoctamin | 7.08e-05 | 10 | 160 | 3 | IPR007632 | |
| Domain | MIR | 7.08e-05 | 10 | 160 | 3 | PS50919 | |
| Domain | MIR | 7.08e-05 | 10 | 160 | 3 | SM00472 | |
| Domain | ATP-grasp_RimK-type | 7.29e-05 | 2 | 160 | 2 | IPR013651 | |
| Domain | SecY_su_dom | 7.29e-05 | 2 | 160 | 2 | IPR023201 | |
| Domain | SECY_1 | 7.29e-05 | 2 | 160 | 2 | PS00755 | |
| Domain | SECY_2 | 7.29e-05 | 2 | 160 | 2 | PS00756 | |
| Domain | - | 7.29e-05 | 2 | 160 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 7.29e-05 | 2 | 160 | 2 | IPR019561 | |
| Domain | SecY_CS | 7.29e-05 | 2 | 160 | 2 | IPR030659 | |
| Domain | Plug_translocon | 7.29e-05 | 2 | 160 | 2 | PF10559 | |
| Domain | RimK | 7.29e-05 | 2 | 160 | 2 | PF08443 | |
| Domain | SecY | 7.29e-05 | 2 | 160 | 2 | PF00344 | |
| Domain | RpS6_RimK/Lys_biosynth_LsyX | 7.29e-05 | 2 | 160 | 2 | IPR004666 | |
| Domain | SecY/SEC61-alpha | 7.29e-05 | 2 | 160 | 2 | IPR002208 | |
| Domain | Spectrin_repeat | 1.04e-04 | 29 | 160 | 4 | IPR002017 | |
| Domain | IQ_motif_EF-hand-BS | 1.24e-04 | 90 | 160 | 6 | IPR000048 | |
| Domain | IQ | 1.48e-04 | 93 | 160 | 6 | PS50096 | |
| Domain | SPEC | 1.55e-04 | 32 | 160 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.55e-04 | 32 | 160 | 4 | IPR018159 | |
| Domain | CarboxyPept_regulatory_dom | 1.66e-04 | 13 | 160 | 3 | IPR014766 | |
| Domain | - | 1.66e-04 | 13 | 160 | 3 | 3.40.50.20 | |
| Domain | - | 1.66e-04 | 13 | 160 | 3 | 2.60.40.1120 | |
| Domain | EF-hand-dom_pair | 1.88e-04 | 287 | 160 | 10 | IPR011992 | |
| Domain | Dynein_HC_stalk | 2.10e-04 | 14 | 160 | 3 | IPR024743 | |
| Domain | ATP_GRASP | 2.10e-04 | 14 | 160 | 3 | PS50975 | |
| Domain | ATP-grasp | 2.10e-04 | 14 | 160 | 3 | IPR011761 | |
| Domain | PreATP-grasp_dom | 2.10e-04 | 14 | 160 | 3 | IPR016185 | |
| Domain | MT | 2.10e-04 | 14 | 160 | 3 | PF12777 | |
| Domain | GART_AS | 2.18e-04 | 3 | 160 | 2 | IPR001555 | |
| Domain | GART | 2.18e-04 | 3 | 160 | 2 | PS00373 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 2.47e-04 | 36 | 160 | 4 | IPR015422 | |
| Domain | DHC_fam | 2.60e-04 | 15 | 160 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.60e-04 | 15 | 160 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.60e-04 | 15 | 160 | 3 | IPR004273 | |
| Domain | - | 2.60e-04 | 15 | 160 | 3 | 3.30.1490.20 | |
| Domain | IQ | 3.58e-04 | 71 | 160 | 5 | PF00612 | |
| Domain | PyrdxlP-dep_Trfase | 4.10e-04 | 41 | 160 | 4 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 4.10e-04 | 41 | 160 | 4 | IPR015421 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 3.40.50.170 | |
| Domain | Formyl_transf_N | 4.33e-04 | 4 | 160 | 2 | IPR002376 | |
| Domain | Formyl_trans_N | 4.33e-04 | 4 | 160 | 2 | PF00551 | |
| Domain | ATP_grasp_subdomain_1 | 4.58e-04 | 18 | 160 | 3 | IPR013815 | |
| Domain | - | 4.58e-04 | 18 | 160 | 3 | 3.30.470.20 | |
| Domain | - | 6.68e-04 | 222 | 160 | 8 | 1.25.10.10 | |
| Domain | ARM-type_fold | ARMC3 CUL9 HEATR1 CLHC1 RYR3 HEATR9 CFAP69 TNPO3 AGTPBP1 ARMC8 | 6.99e-04 | 339 | 160 | 10 | IPR016024 |
| Domain | Groucho_enhance | 7.17e-04 | 5 | 160 | 2 | IPR009146 | |
| Domain | - | 7.17e-04 | 5 | 160 | 2 | 1.10.1200.10 | |
| Domain | TLE_N | 7.17e-04 | 5 | 160 | 2 | PF03920 | |
| Domain | PHOSPHOPANTETHEINE | 7.17e-04 | 5 | 160 | 2 | PS00012 | |
| Domain | Groucho/TLE_N | 7.17e-04 | 5 | 160 | 2 | IPR005617 | |
| Domain | PP-binding | 7.17e-04 | 5 | 160 | 2 | PF00550 | |
| Domain | ACP_DOMAIN | 7.17e-04 | 5 | 160 | 2 | PS50075 | |
| Domain | DUF1785 | 7.17e-04 | 5 | 160 | 2 | SM01163 | |
| Domain | ACTININ_2 | 9.63e-04 | 23 | 160 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.63e-04 | 23 | 160 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.63e-04 | 23 | 160 | 3 | IPR001589 | |
| Domain | EFhand_Ca_insen | 1.07e-03 | 6 | 160 | 2 | PF08726 | |
| Domain | ArgoL1 | 1.07e-03 | 6 | 160 | 2 | PF08699 | |
| Domain | EF-hand_Ca_insen | 1.07e-03 | 6 | 160 | 2 | IPR014837 | |
| Domain | ArgoL1 | 1.07e-03 | 6 | 160 | 2 | IPR014811 | |
| Domain | PP-bd_ACP | 1.07e-03 | 6 | 160 | 2 | IPR009081 | |
| Domain | PIWI | 1.97e-03 | 8 | 160 | 2 | PS50822 | |
| Domain | Piwi | 1.97e-03 | 8 | 160 | 2 | SM00950 | |
| Domain | PyrdxlP-dep_de-COase | 1.97e-03 | 8 | 160 | 2 | IPR002129 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.27e-07 | 130 | 125 | 10 | M27454 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.65e-07 | 31 | 125 | 6 | M877 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | ABCC9 ACTN3 RYR1 RYR2 RYR3 SCN1A SCN2A SCN4A SCN8A SCN9A ATP1A4 | 1.87e-06 | 203 | 125 | 11 | M5485 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 8.41e-06 | 32 | 125 | 5 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.19e-05 | 121 | 125 | 8 | M872 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.65e-05 | 176 | 125 | 9 | MM15718 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.76e-05 | 99 | 125 | 7 | MM14910 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.61e-05 | 183 | 125 | 9 | M997 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.29e-05 | 106 | 125 | 7 | M27200 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.07e-04 | 11 | 125 | 3 | M47958 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.13e-04 | 54 | 125 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.13e-04 | 54 | 125 | 5 | MM15202 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.82e-04 | 13 | 125 | 3 | M39589 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 1.82e-04 | 13 | 125 | 3 | M46426 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.94e-04 | 19 | 125 | 3 | M47760 | |
| Pubmed | KRT16 ARMC3 SYNE1 SMCHD1 SPTA1 SRP72 GRIA3 CCT2 HEATR1 ACTN3 LETM1 RYR2 KRT23 SEC61A2 FASN RIMKLB SACS TJP1 FAM186A EIF4A1 SCN4A SCN9A MACF1 BOD1L1 CEP295 ATP1A4 SEC61A1 CFAP69 TOP2A DOP1A | 1.01e-11 | 1442 | 166 | 30 | 35575683 | |
| Pubmed | PDXDC1 CACNA2D1 HBS1L MARS1 SMCHD1 GART CD109 SRP72 CCT2 TXNDC12 COL18A1 FASN TMTC3 G3BP1 GCAT NOMO2 TJP1 EIF4A1 MACF1 AKAP13 BOD1L1 TAGLN2 FLOT1 SEC61A1 CAPRIN1 TNPO3 PIGO | 1.24e-10 | 1297 | 166 | 27 | 33545068 | |
| Pubmed | 2.89e-10 | 9 | 166 | 5 | 16382098 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | DNHD1 ABCA13 MARS1 TXNDC12 RYR1 EIF4A1 TLN2 BOD1L1 DNM1 SEC61A1 DOP1A | 5.63e-09 | 208 | 166 | 11 | 33230847 |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 7.45e-09 | 6 | 166 | 4 | 23652591 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 HBS1L DNAH10 HTRA2 MARS1 SYNE1 SMCHD1 GART SRP72 CCT2 HEATR1 LETM1 NOMO1 NMD3 FASN G3BP1 EIF4A1 TLN2 BOD1L1 TAGLN2 FLOT1 SEC61A1 CAPRIN1 TOP2A ARMC8 | 1.99e-08 | 1425 | 166 | 25 | 30948266 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.49e-08 | 139 | 166 | 9 | 16985003 | |
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 15746173 | ||
| Pubmed | CACNA2D1 KRT16 MARS1 SYNE1 SPTA1 SRP72 CCT2 ALDH1L1 ACTN3 LETM1 FASN PTPRA G3BP1 SACS TJP1 SCN2A C1QB MACF1 TLN2 DNM1 FLOT1 CAPRIN1 AGTPBP1 ARMC8 | 9.08e-08 | 1431 | 166 | 24 | 37142655 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 18403125 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 36011023 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 7876312 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.07e-07 | 3 | 166 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.07e-07 | 3 | 166 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.07e-07 | 3 | 166 | 3 | 10473538 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 28784306 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 18434746 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 26558388 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.07e-07 | 3 | 166 | 3 | 9204703 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 21881589 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 32845893 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.07e-07 | 3 | 166 | 3 | 12213830 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 28518218 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 9242641 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 17928448 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 25239916 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 18643873 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 11159936 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.07e-07 | 3 | 166 | 3 | 25576386 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.07e-07 | 3 | 166 | 3 | 4600883 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 7635066 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.61e-07 | 11 | 166 | 4 | 32820719 | |
| Pubmed | MARS1 SMCHD1 GART CCT2 ITGA2B CEMIP2 NOMO1 COL18A1 FASN GCAT NOMO2 EIF4A1 COPS6 CAPRIN1 NOMO3 | 2.87e-07 | 613 | 166 | 15 | 22268729 | |
| Pubmed | 3.46e-07 | 13 | 166 | 4 | 15123669 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 17537961 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 4.26e-07 | 4 | 166 | 3 | 23413940 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 9607712 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 23482488 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 18206662 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 35031483 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 29578003 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 21156207 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 4.26e-07 | 4 | 166 | 3 | 31833031 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 9384575 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 4.26e-07 | 4 | 166 | 3 | 8974318 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 9267806 | ||
| Pubmed | 4.92e-07 | 197 | 166 | 9 | 36604605 | ||
| Pubmed | DAB2IP TTC28 SYNE1 CUL9 TENM2 ADCY3 TBC1D1 TLE3 MACF1 BOD1L1 AGTPBP1 PDZD2 | 6.77e-07 | 407 | 166 | 12 | 12693553 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | HBS1L SMCHD1 HEATR1 G3BP1 SACS TJP1 MACF1 TLN2 BOD1L1 SMS TAGLN2 TNPO3 TOP2A | 8.99e-07 | 498 | 166 | 13 | 36634849 |
| Pubmed | NR2C1 TTC28 SYNE1 CUL9 CCT2 RYR3 PTPRA FBH1 SACS NOMO2 TJP1 EIF4A1 MACF1 TLN2 EIF2AK1 DNM1 FLOT1 LNX1 CAPRIN1 AGTPBP1 ARMC8 | 9.46e-07 | 1285 | 166 | 21 | 35914814 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 8812438 | ||
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.06e-06 | 5 | 166 | 3 | 19011160 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 17724025 | ||
| Pubmed | UBA5 STX8 HTRA2 CCT2 DDB2 PARS2 SEC61A2 COL18A1 PTPRA G3BP1 TJP1 PI4KB | 1.42e-06 | 437 | 166 | 12 | 20562859 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.58e-06 | 168 | 166 | 8 | 30631154 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 2.11e-06 | 6 | 166 | 3 | 26025922 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 2.11e-06 | 6 | 166 | 3 | 14592808 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.11e-06 | 6 | 166 | 3 | 25966694 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 19009018 | ||
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.11e-06 | 6 | 166 | 3 | 16844763 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CACNA2D1 KRT16 MARS1 SYNE1 SMCHD1 GART CCT2 HEATR1 F5 FASN G3BP1 SACS TJP1 EIF4A1 MACF1 TAGLN2 FLOT1 TOP2A | 2.19e-06 | 1024 | 166 | 18 | 24711643 |
| Pubmed | ZNF143 TTC28 ACADSB CHD7 MORC4 RYR1 RYR2 RAD51AP2 SALL1 TMTC3 PI4KB TLE3 CEP295 NOMO3 | 2.59e-06 | 638 | 166 | 14 | 31182584 | |
| Pubmed | STX8 ACADSB SYNE1 ZDHHC5 HEATR1 LETM1 CEMIP2 NOMO1 SEC61A2 COL18A1 AIFM2 TMTC3 SACS NOMO2 MACF1 AKAP13 AKAP11 VAMP8 FLOT1 SEC61A1 CAPRIN1 AGTPBP1 | 2.60e-06 | 1487 | 166 | 22 | 33957083 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.69e-06 | 7 | 166 | 3 | 25818041 | |
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 11860456 | ||
| Pubmed | ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. | 3.69e-06 | 7 | 166 | 3 | 22075693 | |
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 20962236 | ||
| Pubmed | 4.11e-06 | 191 | 166 | 8 | 33762435 | ||
| Pubmed | 4.13e-06 | 23 | 166 | 4 | 37873566 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | UBA5 SMCHD1 FERMT1 SRP72 CCT2 CHD7 TRUB1 FASN EIF4A1 MACF1 TLN2 COPS6 TOP2A | 4.94e-06 | 582 | 166 | 13 | 20467437 |
| Pubmed | The anoctamin family: TMEM16A and TMEM16B as calcium-activated chloride channels. | 5.88e-06 | 8 | 166 | 3 | 21984732 | |
| Pubmed | 5.88e-06 | 8 | 166 | 3 | 20056604 | ||
| Pubmed | 5.88e-06 | 8 | 166 | 3 | 11784029 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 5.88e-06 | 8 | 166 | 3 | 15257293 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.88e-06 | 8 | 166 | 3 | 19033399 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | PDXDC1 STX8 ATP7B CCT2 NOMO1 FASN NOMO2 EIF4A1 TAGLN2 VAMP8 SEC61A1 NOMO3 | 7.73e-06 | 516 | 166 | 12 | 36610398 |
| Pubmed | KRT16 MARS1 SMCHD1 GART CCT2 HEATR1 FASN G3BP1 EIF4A1 MACF1 TAGLN2 VAMP8 FLOT1 TOP2A | 8.34e-06 | 707 | 166 | 14 | 19738201 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 MARS1 SYNE1 SPTA1 GART CCT2 ALDH1L1 RYR1 FASN EIF4A1 SCN8A MACF1 AKAP13 SMS TAGLN2 | 8.35e-06 | 807 | 166 | 15 | 30575818 |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 8.78e-06 | 9 | 166 | 3 | 36261522 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PDXDC1 ACADSB HTRA2 MARS1 GART CCT2 MORC4 WTAP NOMO1 SEC61A2 FASN G3BP1 GCAT NOMO2 EIF4A1 PIPSL COPS6 SEC61A1 NOMO3 | 9.82e-06 | 1257 | 166 | 19 | 37317656 |
| Pubmed | NR2C1 ATP7B TTC28 CHD7 CEMIP2 TMTC3 NOMO2 TJP1 TLE1 AKAP13 BOD1L1 CEP295 VAMP8 AGTPBP1 | 1.25e-05 | 733 | 166 | 14 | 34672954 | |
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 1.25e-05 | 10 | 166 | 3 | 23532839 | |
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 1.25e-05 | 10 | 166 | 3 | 19015192 | |
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 24692353 | ||
| Pubmed | 1.36e-05 | 225 | 166 | 8 | 12168954 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ACADSB ABCA13 SMCHD1 CHD7 HEATR1 TENM2 RYR1 KRT23 KAT7 TJP1 AKAP11 NOMO3 | 1.51e-05 | 552 | 166 | 12 | 10737800 |
| Pubmed | 1.53e-05 | 110 | 166 | 6 | 27889896 | ||
| Pubmed | SMCHD1 GART CUL9 SRP72 CCT2 CHD7 HEATR1 FASN G3BP1 TJP1 EIF4A1 MACF1 CAPRIN1 | 1.67e-05 | 653 | 166 | 13 | 22586326 | |
| Pubmed | SMCHD1 GART CD109 ZDHHC5 HEATR1 F5 KAT7 TJP1 EIF4A1 MACF1 FLOT1 CAPRIN1 TOP2A | 1.87e-05 | 660 | 166 | 13 | 32780723 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 SMCHD1 CD109 HEATR1 NOMO1 TYK2 FASN PTPRA TMTC3 TJP1 SMS TAGLN2 PIPSL SEC61A1 TNPO3 ARMC8 | 1.90e-05 | 974 | 166 | 16 | 28675297 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | PDXDC1 ZNF143 FASTKD1 GART CD109 CCT2 PLA2G2E TXNDC12 NOMO1 FASN TMTC3 GCAT NOMO2 TJP1 TLE1 EIF4A1 VAMP8 SEC61A1 PIGO NOMO3 | 2.14e-05 | 1451 | 166 | 20 | 30550785 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DNHD1 SMCHD1 ZDHHC5 SYCP3 NOMO1 FASN G3BP1 TBC1D1 EIF4A1 TAGLN2 EIF2AK1 SEC61A1 NOMO3 | 2.19e-05 | 670 | 166 | 13 | 22990118 |
| Pubmed | Fatty acid synthase regulates the pathogenicity of Th17 cells. | 2.26e-05 | 2 | 166 | 2 | 28848043 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.26e-05 | 2 | 166 | 2 | 37901435 | |
| Interaction | SOX6 interactions | 5.68e-06 | 157 | 164 | 9 | int:SOX6 | |
| Interaction | FBXO6 interactions | MARS1 SMCHD1 GART CD109 LAMA3 CCT2 ITGA2B CEMIP2 NOMO1 COL18A1 FASN TMTC3 GCAT NOMO2 EIF4A1 COPS6 CAPRIN1 NOMO3 | 2.30e-05 | 717 | 164 | 18 | int:FBXO6 |
| Interaction | CCDC8 interactions | CACNA2D1 KRT16 MARS1 SMCHD1 GART CUL9 CCT2 HEATR1 F5 FASN G3BP1 SACS TJP1 EIF4A1 MACF1 FLOT1 TOP2A | 2.64e-05 | 656 | 164 | 17 | int:CCDC8 |
| Interaction | KCNA3 interactions | DNHD1 HBS1L TTC28 ABCA13 MARS1 GART ZDHHC5 SRP72 CCT2 LETM1 RYR1 FASN EIF4A1 MACF1 TLN2 BOD1L1 TAF7 DNM1 SEC61A1 DOP1A | 2.83e-05 | 871 | 164 | 20 | int:KCNA3 |
| Interaction | SCN4B interactions | 2.88e-05 | 8 | 164 | 3 | int:SCN4B | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.03e-09 | 9 | 112 | 5 | 1203 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.31e-07 | 3 | 112 | 3 | 287 | |
| GeneFamily | Anoctamins | 2.69e-05 | 10 | 112 | 3 | 865 | |
| GeneFamily | Argonaute/PIWI family | 1.04e-03 | 8 | 112 | 2 | 408 | |
| GeneFamily | PDZ domain containing | 2.56e-03 | 152 | 112 | 5 | 1220 | |
| GeneFamily | ATP binding cassette subfamily C | 2.84e-03 | 13 | 112 | 2 | 807 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.67e-03 | 50 | 112 | 3 | 1293 | |
| GeneFamily | Dyneins, axonemal | 4.87e-03 | 17 | 112 | 2 | 536 | |
| GeneFamily | DNA helicases | 4.87e-03 | 17 | 112 | 2 | 1167 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.39e-03 | 181 | 112 | 5 | 694 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO2 DNAH10 ABCA13 SPTA1 OBSCN RYR2 RYR3 SCN2A SCN9A TLN2 ONECUT3 ATP1A4 | 5.76e-12 | 184 | 167 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO2 DNAH10 ABCA13 SPTA1 OBSCN RYR2 RYR3 SCN2A SCN9A TLN2 ONECUT3 ATP1A4 | 5.76e-12 | 184 | 167 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ANO2 DNAH10 ABCA13 SPTA1 OBSCN RYR2 RYR3 SCN2A SCN9A TLN2 ONECUT3 ATP1A4 | 5.76e-12 | 184 | 167 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DAB2IP TTYH2 OBSCN ANO1 ABCC9 ADCY3 RYR2 COL18A1 TJP1 EGFLAM | 2.43e-09 | 187 | 167 | 10 | a2bf958ea59c359a265bfa437d59315e1920cdd4 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.64e-09 | 200 | 167 | 10 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.54e-08 | 185 | 167 | 9 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.34e-08 | 198 | 167 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 6.91e-08 | 200 | 167 | 9 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-07 | 175 | 167 | 8 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-07 | 181 | 167 | 8 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-07 | 181 | 167 | 8 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 186 | 167 | 8 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 5.99e-07 | 189 | 167 | 8 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-07 | 193 | 167 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-07 | 193 | 167 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-07 | 193 | 167 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.88e-07 | 196 | 167 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.50e-07 | 198 | 167 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.50e-07 | 198 | 167 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.17e-07 | 200 | 167 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.17e-07 | 200 | 167 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.17e-07 | 200 | 167 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.17e-07 | 200 | 167 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.17e-07 | 200 | 167 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 9.17e-07 | 200 | 167 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-06 | 150 | 167 | 7 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 158 | 167 | 7 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 158 | 167 | 7 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 167 | 167 | 7 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 169 | 167 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.48e-06 | 175 | 167 | 7 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 4.83e-06 | 177 | 167 | 7 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-06 | 178 | 167 | 7 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 5.59e-06 | 181 | 167 | 7 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.59e-06 | 181 | 167 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 182 | 167 | 7 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.80e-06 | 182 | 167 | 7 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 182 | 167 | 7 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 182 | 167 | 7 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 6.01e-06 | 183 | 167 | 7 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.23e-06 | 184 | 167 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-06 | 184 | 167 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 6.23e-06 | 184 | 167 | 7 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 167 | 7 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 167 | 7 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 167 | 7 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.46e-06 | 121 | 167 | 6 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-06 | 186 | 167 | 7 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.42e-06 | 189 | 167 | 7 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.68e-06 | 190 | 167 | 7 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.68e-06 | 190 | 167 | 7 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.68e-06 | 190 | 167 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.95e-06 | 191 | 167 | 7 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.95e-06 | 191 | 167 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.22e-06 | 192 | 167 | 7 | 7a6dd2ae217b8f8e460d47ad128904408299458c | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-06 | 192 | 167 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.50e-06 | 193 | 167 | 7 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.40e-06 | 196 | 167 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 196 | 167 | 7 | c16fbd23d9e117831b55ab3da5b08b22dd972432 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.40e-06 | 196 | 167 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.72e-06 | 197 | 167 | 7 | fd65a9b41df618ff2a09d76dcf9f1ca3f3bdf52a | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.72e-06 | 197 | 167 | 7 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-05 | 198 | 167 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.21e-05 | 135 | 167 | 6 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_large-bowel / Manually curated celltypes from each tissue | 2.37e-05 | 152 | 167 | 6 | 95944864ce7539ff8de028f5700694931338f3ff | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.46e-05 | 153 | 167 | 6 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 155 | 167 | 6 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 158 | 167 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 158 | 167 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-05 | 159 | 167 | 6 | b05fda31b77536a1878f55d3199563b53f9420b2 | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.05e-05 | 159 | 167 | 6 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.75e-05 | 165 | 167 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 3.88e-05 | 166 | 167 | 6 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 168 | 167 | 6 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.15e-05 | 168 | 167 | 6 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.15e-05 | 168 | 167 | 6 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 168 | 167 | 6 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-05 | 169 | 167 | 6 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D122|Adult / Lineage, Cell type, age group and donor | 4.29e-05 | 169 | 167 | 6 | d5624e5b3687bd3f18f3a2b47a94d11eb1fbdb75 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.43e-05 | 170 | 167 | 6 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 170 | 167 | 6 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.58e-05 | 171 | 167 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 171 | 167 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 4.89e-05 | 173 | 167 | 6 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 174 | 167 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 174 | 167 | 6 | a0a059bb2a64d7011e206db2ebcdf3eb655a925a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.05e-05 | 174 | 167 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 174 | 167 | 6 | 7cd6f9103133f8d7b90f9ff4b3b0b078cf554542 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.21e-05 | 175 | 167 | 6 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 5.55e-05 | 177 | 167 | 6 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 178 | 167 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-early_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-05 | 179 | 167 | 6 | 3f73f89905c061ada4e3eb921fa394d95f95c959 | |
| Drug | chloro-m-cresol | 3.85e-08 | 6 | 164 | 4 | CID000012008 | |
| Drug | Azumoleno | 8.93e-08 | 7 | 164 | 4 | CID000056259 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.46e-07 | 37 | 164 | 6 | CID000009643 | |
| Drug | cis-diammineplatinum(II | 3.67e-07 | 3 | 164 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.67e-07 | 3 | 164 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 3.67e-07 | 3 | 164 | 3 | CID000127713 | |
| Drug | aminodantrolene | 3.67e-07 | 3 | 164 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 3.67e-07 | 3 | 164 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.67e-07 | 3 | 164 | 3 | CID005748312 | |
| Drug | PCB74 | 1.46e-06 | 4 | 164 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.46e-06 | 4 | 164 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.46e-06 | 4 | 164 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.46e-06 | 4 | 164 | 3 | CID000035682 | |
| Drug | LOPAC | 2.25e-06 | 30 | 164 | 5 | CID000062696 | |
| Drug | FPL 64176 | 3.33e-06 | 15 | 164 | 4 | CID000003423 | |
| Drug | sodium | CACNA2D1 ZNF143 ATP7B SLC2A7 GART TMPRSS4 GRIA3 ADCY3 RYR1 RYR2 RYR3 NOMO1 KAT7 SACS TJP1 KCNJ8 SCN2A SCN4A SCN9A ATP1A4 LNX1 | 4.54e-06 | 944 | 164 | 21 | CID000000923 |
| Drug | Zonisamide | 5.74e-06 | 17 | 164 | 4 | DB00909 | |
| Drug | APETx1, Anthopleura elegantissima | 7.22e-06 | 6 | 164 | 3 | ctd:C475726 | |
| Drug | MBED | 7.22e-06 | 6 | 164 | 3 | CID000129958 | |
| Drug | AC1O528X | 7.22e-06 | 6 | 164 | 3 | CID006475857 | |
| Drug | NSC114784 | 7.22e-06 | 6 | 164 | 3 | CID000419425 | |
| Drug | isradipine | 8.08e-06 | 100 | 164 | 7 | CID000003784 | |
| Drug | flecainide | 1.24e-05 | 71 | 164 | 6 | CID000003355 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.26e-05 | 7 | 164 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 1.26e-05 | 7 | 164 | 3 | CID003081001 | |
| Drug | CHEBI:564108 | 1.26e-05 | 7 | 164 | 3 | CID006400637 | |
| Drug | indo-1/AM | 1.41e-05 | 21 | 164 | 4 | CID000123918 | |
| Drug | lamotrigine | 2.14e-05 | 116 | 164 | 7 | CID000003878 | |
| Drug | etridiazole | 2.97e-05 | 50 | 164 | 5 | CID000017432 | |
| Drug | tetracaine | 4.24e-05 | 88 | 164 | 6 | CID000005411 | |
| Drug | PCB 95 | 4.24e-05 | 10 | 164 | 3 | CID000038012 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 5.16e-05 | 2 | 164 | 2 | ctd:C005147 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 5.16e-05 | 2 | 164 | 2 | ctd:C502265 | |
| Drug | NSC7524 | 5.40e-05 | 182 | 164 | 8 | CID000005657 | |
| Drug | PCB 66 | 5.80e-05 | 11 | 164 | 3 | CID000036185 | |
| Drug | R 478 | 5.80e-05 | 11 | 164 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 5.80e-05 | 11 | 164 | 3 | CID003081323 | |
| Drug | M-HN | 7.02e-05 | 31 | 164 | 4 | CID000015450 | |
| Drug | Ryanodine | 7.70e-05 | 12 | 164 | 3 | ctd:D012433 | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; HL60; HG-U133A | 8.76e-05 | 195 | 164 | 8 | 1985_DN | |
| Drug | CNS 1145 | 9.02e-05 | 33 | 164 | 4 | CID000190902 | |
| Drug | IHC-64 | 9.02e-05 | 33 | 164 | 4 | CID000162753 | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.08e-05 | 196 | 164 | 8 | 3516_DN | |
| Drug | CO(2 | STX8 GAD1 CACNA2D1 MARS1 GART ALDH1L1 ADCY3 TYK2 GOT1L1 FASN GCAT | 9.74e-05 | 378 | 164 | 11 | CID000000280 |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 4529_UP | |
| Drug | succinylcholine | 9.87e-05 | 64 | 164 | 5 | CID000005314 | |
| Drug | aprikalim | 9.95e-05 | 13 | 164 | 3 | CID003034038 | |
| Drug | diphenidol | 9.95e-05 | 13 | 164 | 3 | CID000003055 | |
| Drug | ciguatoxin | 1.14e-04 | 35 | 164 | 4 | CID005311333 | |
| Drug | potassium | CACNA2D1 RAPSN SYNE1 SPTA1 GART ABCC9 F5 ADCY3 RYR1 RYR2 RYR3 KCNC2 SACS KCNJ8 SCN2A SCN4A SCN9A TAF7 ATP1A4 | 1.24e-04 | 1008 | 164 | 19 | CID000000813 |
| Drug | bimoclomol | 1.26e-04 | 14 | 164 | 3 | CID009576891 | |
| Drug | AC1L1F95 | 1.26e-04 | 14 | 164 | 3 | CID000003137 | |
| Drug | arabinosyladenine | GPLD1 CACNA2D1 ATP7B MARS1 SPTA1 GART ABCC9 GRIA3 ITGA2B F5 ADCY3 RYR1 RYR2 RYR3 PI4KB KCNJ8 | 1.30e-04 | 762 | 164 | 16 | CID000000191 |
| Drug | sipatrigine | 1.42e-04 | 37 | 164 | 4 | CID000060803 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.54e-04 | 3 | 164 | 2 | ctd:C561228 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.54e-04 | 3 | 164 | 2 | CID000080262 | |
| Drug | flubendiamide | 1.54e-04 | 3 | 164 | 2 | CID011193251 | |
| Drug | NSC-40277 | 1.54e-04 | 3 | 164 | 2 | CID000237064 | |
| Drug | Gvapspat amide | 1.57e-04 | 15 | 164 | 3 | CID000125015 | |
| Drug | nonanol | 1.57e-04 | 15 | 164 | 3 | CID000008914 | |
| Drug | AC1L98DX | 1.58e-04 | 38 | 164 | 4 | CID000439957 | |
| Drug | lidocaine | 1.64e-04 | 160 | 164 | 7 | CID000003676 | |
| Drug | CID9959010 | 1.75e-04 | 39 | 164 | 4 | CID009959010 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.19e-09 | 10 | 163 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.19e-09 | 10 | 163 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.71e-09 | 12 | 163 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.65e-07 | 3 | 163 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.65e-07 | 3 | 163 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.32e-07 | 163 | 163 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.36e-05 | 9 | 163 | 3 | C3502809 | |
| Disease | Tachycardia, Ventricular | 2.64e-05 | 11 | 163 | 3 | C0042514 | |
| Disease | Shortened QT interval | 2.64e-05 | 11 | 163 | 3 | C0151879 | |
| Disease | Cantu syndrome | 3.03e-05 | 2 | 163 | 2 | C0795905 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 3.03e-05 | 2 | 163 | 2 | C4551549 | |
| Disease | hypertrichotic osteochondrodysplasia Cantu type (implicated_via_orthology) | 3.03e-05 | 2 | 163 | 2 | DOID:0060569 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 4.54e-05 | 13 | 163 | 3 | C0751122 | |
| Disease | phosphatidylcholine 40:7 measurement | 4.54e-05 | 13 | 163 | 3 | EFO_0021477 | |
| Disease | phosphatidylcholine 38:6 measurement | 8.79e-05 | 16 | 163 | 3 | EFO_0010388 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 8.79e-05 | 16 | 163 | 3 | C0393706 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 8.79e-05 | 16 | 163 | 3 | OBA_2045093 | |
| Disease | B Virus Infection | 9.07e-05 | 3 | 163 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 9.07e-05 | 3 | 163 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 9.07e-05 | 3 | 163 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 9.07e-05 | 3 | 163 | 2 | C0019372 | |
| Disease | 1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3) measurement | 9.07e-05 | 3 | 163 | 2 | EFO_0800461 | |
| Disease | age at assessment, pelvic organ prolapse | 9.36e-05 | 43 | 163 | 4 | EFO_0004710, EFO_0008007 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.50e-04 | 19 | 163 | 3 | OBA_2045199 | |
| Disease | Bone Marrow failure syndromes | 1.81e-04 | 4 | 163 | 2 | C2931245 | |
| Disease | Bone marrow failure syndrome 2 | 1.81e-04 | 4 | 163 | 2 | C3810350 | |
| Disease | 1-dihomo-linolenoyl-GPC (20:3n3 or 6) measurement | 1.81e-04 | 4 | 163 | 2 | EFO_0800235 | |
| Disease | Bone marrow failure syndrome 1 | 1.81e-04 | 4 | 163 | 2 | C3808553 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.36e-04 | 22 | 163 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | insulin sensitivity measurement | 2.70e-04 | 23 | 163 | 3 | EFO_0004471 | |
| Disease | Liver Cirrhosis | 2.74e-04 | 103 | 163 | 5 | C0023890 | |
| Disease | Fibrosis, Liver | 2.99e-04 | 105 | 163 | 5 | C0239946 | |
| Disease | Cerebellar Ataxia | 3.00e-04 | 5 | 163 | 2 | C0007758 | |
| Disease | 1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement | 3.00e-04 | 5 | 163 | 2 | EFO_0800407 | |
| Disease | Brugada Syndrome (disorder) | 3.08e-04 | 24 | 163 | 3 | C1142166 | |
| Disease | Malignant neoplasm of breast | ATP7B SYNE1 CD109 OBSCN OR12D3 SLC22A18 FASN CSF1R TLE3 HEATR9 C1QB MACF1 ZFYVE26 BOD1L1 TOP2A DOP1A | 3.16e-04 | 1074 | 163 | 16 | C0006142 |
| Disease | Epilepsy | 3.56e-04 | 109 | 163 | 5 | C0014544 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 4.48e-04 | 6 | 163 | 2 | C1854678 | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 4.48e-04 | 6 | 163 | 2 | C3463992 | |
| Disease | Lennox-Gastaut syndrome | 4.48e-04 | 6 | 163 | 2 | C0238111 | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 4.48e-04 | 6 | 163 | 2 | C3853779 | |
| Disease | FNAITP | 4.48e-04 | 6 | 163 | 2 | C3854603 | |
| Disease | dihomo-linolenate 20:3n3 or n6 measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0021046 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0800390 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0800434 | |
| Disease | Familial benign neonatal epilepsy | 4.48e-04 | 6 | 163 | 2 | C0220669 | |
| Disease | Lissencephaly | 4.48e-04 | 6 | 163 | 2 | C0266463 | |
| Disease | 1-dihomo-linolenoyl-GPE (20:3n3 or 6) measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0800358 | |
| Disease | neuroblastoma | 4.74e-04 | 116 | 163 | 5 | EFO_0000621 | |
| Disease | corpus callosum central volume measurement | 4.90e-04 | 28 | 163 | 3 | EFO_0010296 | |
| Disease | aortic measurement | 5.12e-04 | 251 | 163 | 7 | EFO_0020865 | |
| Disease | Seizure, Febrile, Simple | 6.25e-04 | 7 | 163 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 6.25e-04 | 7 | 163 | 2 | C0751057 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 7.41e-04 | 128 | 163 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 7.41e-04 | 128 | 163 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 7.41e-04 | 128 | 163 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 7.41e-04 | 128 | 163 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 7.41e-04 | 128 | 163 | 5 | C0007134 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 8.31e-04 | 8 | 163 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 8.31e-04 | 8 | 163 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 8.31e-04 | 8 | 163 | 2 | C0338479 | |
| Disease | X-linked infantile spasms | 8.31e-04 | 8 | 163 | 2 | C4552072 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 8.31e-04 | 8 | 163 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 8.31e-04 | 8 | 163 | 2 | C0438414 | |
| Disease | fatty acid desaturase enzyme activity measurement | 8.31e-04 | 8 | 163 | 2 | EFO_0009791 | |
| Disease | Myoclonic Absence Epilepsy | 8.31e-04 | 8 | 163 | 2 | C0393703 | |
| Disease | triacylglycerol 58:10 measurement | 8.73e-04 | 34 | 163 | 3 | EFO_0010437 | |
| Disease | Intellectual Disability | 8.91e-04 | 447 | 163 | 9 | C3714756 | |
| Disease | total iron binding capacity | 9.32e-04 | 78 | 163 | 4 | EFO_0006334 | |
| Disease | platelet component distribution width | HBS1L RAPSN ARMC3 SYNE1 SPTA1 ITGA2B COL18A1 G3BP1 MACF1 AKAP13 TAGLN2 DNM1 | 1.04e-03 | 755 | 163 | 12 | EFO_0007984 |
| Disease | Febrile Convulsions | 1.06e-03 | 9 | 163 | 2 | C0009952 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 1.06e-03 | 9 | 163 | 2 | OBA_2045130 | |
| Disease | Myoclonic Epilepsy | 1.06e-03 | 9 | 163 | 2 | C0014550 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement | 1.06e-03 | 9 | 163 | 2 | EFO_0800271 | |
| Disease | Profound Mental Retardation | 1.07e-03 | 139 | 163 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.07e-03 | 139 | 163 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.07e-03 | 139 | 163 | 5 | C0917816 | |
| Disease | Epilepsy, Cryptogenic | 1.12e-03 | 82 | 163 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.12e-03 | 82 | 163 | 4 | C0751111 | |
| Disease | Aura | 1.12e-03 | 82 | 163 | 4 | C0236018 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 1.21e-03 | 38 | 163 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.33e-03 | 10 | 163 | 2 | C0917800 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 1.33e-03 | 10 | 163 | 2 | OBA_2045075 | |
| Disease | fat body mass | 1.35e-03 | 217 | 163 | 6 | EFO_0005409 | |
| Disease | Inherited neuropathies | 1.41e-03 | 40 | 163 | 3 | C0598589 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.42e-03 | 148 | 163 | 5 | C0279702 | |
| Disease | Other specified cardiac arrhythmias | 1.61e-03 | 11 | 163 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 1.61e-03 | 11 | 163 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 1.61e-03 | 11 | 163 | 2 | C1399226 | |
| Disease | Paranoia | 1.61e-03 | 11 | 163 | 2 | C1456784 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.61e-03 | 11 | 163 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 1.61e-03 | 11 | 163 | 2 | C2748542 | |
| Disease | Myoclonic Astatic Epilepsy | 1.61e-03 | 11 | 163 | 2 | C0393702 | |
| Disease | heart rate | 1.62e-03 | 225 | 163 | 6 | EFO_0004326 | |
| Disease | beta-nerve growth factor measurement | 1.62e-03 | 42 | 163 | 3 | EFO_0008035 | |
| Disease | spleen volume | 1.74e-03 | 43 | 163 | 3 | EFO_0600047 | |
| Disease | Neurodevelopmental Disorders | 1.79e-03 | 93 | 163 | 4 | C1535926 | |
| Disease | Colorectal Carcinoma | ATP7B ABCA13 SYNE1 CD109 OBSCN ALDH1L1 F5 GMCL2 SACS PIGO AGTPBP1 | 1.88e-03 | 702 | 163 | 11 | C0009402 |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0800500 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.93e-03 | 12 | 163 | 2 | OBA_2045152 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGVKNIMTQNVERIL | 21 | Q9BV40 | |
| IMNVNVKGTQLLLEA | 96 | P26439 | |
| NGILQVDKQKIVEGM | 706 | Q63HQ2 | |
| SLSQVAMLVVNQGKG | 206 | Q86XM0 | |
| ALIGKQEGRNIEVMN | 71 | Q7L5N1 | |
| EKIVVLGQVLMNESL | 56 | H3BNL8 | |
| SIEGMISQLEGVQQI | 376 | P35670 | |
| EGVGMLVVVAVNNQQ | 256 | Q8NHS2 | |
| GVMLKLVEQINISQD | 41 | Q9BQL6 | |
| MKSAINEVEILQGLV | 2421 | Q12802 | |
| TGNLVVNLLVGLMEK | 1701 | Q86UQ4 | |
| KSVIQGLFQQGLMGI | 91 | P45954 | |
| QILKQEGGNSELIMD | 1351 | Q9UKA4 | |
| ELLVQAMVGILQVNG | 326 | Q5JWR5 | |
| GEMTLGQINNLVAIE | 406 | O60706 | |
| TMVQIQQTGGLKKLL | 266 | Q5W041 | |
| ENMIQTLTGGLQSVK | 576 | Q96M86 | |
| LLGMATQCVQVKNVV | 531 | Q9HCK5 | |
| LSIIMLGKQLIQNNI | 681 | Q9NQ90 | |
| VTKGGSQILLQLLMN | 106 | Q9UPW5 | |
| VNSVSLGKNGVVELM | 191 | Q9UPW5 | |
| LVIGPQQQFLVMKQT | 321 | A4D256 | |
| TGAVQTEAMKQILGV | 46 | Q14444 | |
| QLQAMIQAAGKLVLI | 1281 | Q9P2D1 | |
| QIGIIGIQNLITRNM | 541 | Q09MP3 | |
| MGEIVTEQQTGQKIQ | 16 | P13056 | |
| MIEVQEGQNLKITIT | 941 | P69849 | |
| MTEIGNRLGQVQALL | 276 | Q13702 | |
| GKQLAIQVSNILGMD | 241 | Q8IXN7 | |
| LGVTQLAVAVNKMDQ | 396 | Q9Y450 | |
| AQELLVIMVGKQVIN | 641 | Q6IWH7 | |
| LQTNMANLKVIGIVI | 16 | Q8N635 | |
| GLQKMVIENDLSGLI | 681 | Q5VWQ8 | |
| ILTKQRMIDNGIGVD | 351 | O75140 | |
| MIEVQEGQNLKITIT | 941 | Q5JPE7 | |
| LQGQITEGSNMIKTI | 326 | O95251 | |
| MGKIENNERVILNVG | 1 | Q96PR1 | |
| LQNIVGLIINAVMLG | 161 | Q15842 | |
| MGEQLRLVKSQLQGL | 1836 | Q16787 | |
| SIIVLMAGQQLSGIN | 286 | Q6PXP3 | |
| QGQRTIGVITKLDLM | 196 | Q05193 | |
| QVTLQELTGGKAMTQ | 361 | Q99665 | |
| RVQQMIGQIDGLISQ | 611 | O95202 | |
| ILVKEKGILQGCNQM | 416 | Q99259 | |
| GIDIERALKMVQVQG | 351 | P42263 | |
| TGIAQVKIQGQNKEM | 66 | O75955 | |
| ELAQQIQKVVMALGD | 111 | P60842 | |
| EILSLNGQLMVGVDV | 141 | O15018 | |
| LQGSGQDMVSILQLV | 51 | Q6P996 | |
| LQGSGQDMVSILQLV | 51 | Q6P474 | |
| QAMVLLGVKLSGVQD | 531 | P39060 | |
| MIEVQEGQNLKITIT | 941 | Q15155 | |
| GLLVGSEKVTMQNLN | 111 | P08779 | |
| EQIVDGKMTNAQIIL | 131 | Q9C075 | |
| MKLQQVNGLGQGLIQ | 1416 | O94854 | |
| GDIILKVNGMDISNV | 321 | Q8TBB1 | |
| IIMLGKQLIQNNLFE | 666 | Q5XXA6 | |
| GVMDQVTIINSTLGK | 251 | O75600 | |
| VVTGDNVGNVILLNM | 216 | Q92466 | |
| KLDIGIINENQRVSM | 56 | Q96PD4 | |
| TGGKNIRIVVMNNLL | 181 | A2A3N6 | |
| NLIGNGSILVMVVLE | 36 | Q9UGF7 | |
| VVSQGRQQMLVIKGF | 4671 | Q5VST9 | |
| LVTGNLVQFGVMIEK | 16 | Q9NZK7 | |
| NIRQQVLKSGMLESG | 116 | Q8NFC6 | |
| VLQGVIDMKNAVIGN | 36 | Q8IUR7 | |
| IVGIVAVDKSVNLMN | 586 | Q6YHK3 | |
| QEVTVGEGLNLKVMV | 311 | P07333 | |
| VNLDGEVIGVNTMKV | 311 | O43464 | |
| QRVMVEQSEKLNGVL | 586 | Q8NFZ0 | |
| SGNVNLTLQMKIIEQ | 586 | Q9BQI3 | |
| KTNLKNQLILGVMGV | 476 | P54289 | |
| NQLILGVMGVDVSLE | 481 | P54289 | |
| NIQGQVQKEIDLIMG | 331 | Q6VVX0 | |
| LNDGVVVQVMGLLSN | 86 | Q13283 | |
| QQIFKMLAEVLGGIN | 701 | Q53R41 | |
| GVTVAQQQQEELKGM | 206 | O60266 | |
| GMVLKLEQGENVFLQ | 211 | P02746 | |
| SLLQGTIQMIQERLG | 321 | Q9UHN6 | |
| VNLLTIIGNSMGLVN | 666 | Q0VDD8 | |
| ELLTNQVGEKMVVVQ | 736 | Q8IWT3 | |
| VLQGVNGEMVLSQLL | 1021 | Q9H583 | |
| MGGNFEIIIKQILQD | 1116 | Q8NDH2 | |
| QILQDKIAAGMLLNV | 1126 | Q8NDH2 | |
| VRIGLTGTILQNNMK | 306 | Q5T890 | |
| NTKVSEIQGMLQELI | 231 | A6NE01 | |
| EGMQSTILVLQQQLK | 216 | Q15007 | |
| VQRVGKSVLVGNINM | 181 | Q969P5 | |
| AELQKVLQGDLVMNV | 1491 | P49327 | |
| GTIQQMIGIFKNIIS | 506 | A5D8W1 | |
| KRGVVTMLQSQGLIE | 2286 | Q9C0D2 | |
| MGQGQEKVALQLLET | 3911 | Q8IVF4 | |
| EVVKTRMQLQGELQA | 21 | Q3KQZ1 | |
| LLLFGQGVKTMQVVE | 96 | Q9BZV2 | |
| AMKANEISVIQNGGI | 1246 | Q9NSC2 | |
| KSRIQGNIGVQMLVD | 3931 | Q9NZJ4 | |
| ISILNGGNAEVQQKM | 3801 | P21817 | |
| LEGNVVNGTIGKQMV | 3986 | Q92736 | |
| GKGMISIIAAVQKQQ | 706 | P18433 | |
| KEMQVTISQQLGLEL | 441 | O60422 | |
| GIIVIKDNMAQEGVI | 161 | Q9BV86 | |
| QKLINQSLVMGIEVG | 896 | Q9P2F6 | |
| LVRVIDQEMQAIGGQ | 101 | Q7L3T8 | |
| NEGTNQLVMGIQKQI | 271 | Q15545 | |
| TILKGLQSIFQEQGM | 21 | P52788 | |
| QGIESQEERQGKMLL | 76 | Q8N2I9 | |
| VQMGQELQGEVVIII | 1161 | A6NHR9 | |
| QKLFGMIITIGQAIV | 116 | Q9H9S3 | |
| LNMLIKIIGNSVGAL | 686 | P35499 | |
| QNMLEGVGVDINKAL | 71 | Q8IZU3 | |
| VMADLGLNERQVIQK | 4411 | Q8NF91 | |
| IAKLQGGQILMGQEL | 621 | Q14C87 | |
| QLQEGKNVIGLQMGT | 166 | P37802 | |
| DMQKEVIITGIQTQG | 1966 | P12259 | |
| LVVGIDLKNQMVLLQ | 81 | Q9BRQ8 | |
| IQSTLGAEGKIQMVV | 656 | Q8TC59 | |
| ELGINVMKQLIGSSN | 251 | Q8NEA9 | |
| ILTVQEMAGLNNKTI | 511 | Q8TE76 | |
| TLNMLIKIIGNSVGA | 851 | Q15858 | |
| LMVTNDGATILKNIG | 61 | P78371 | |
| GLKVVSTQNLELGLM | 1666 | Q9NT68 | |
| VTVAGNLGMIVLIQA | 36 | Q8NGP6 | |
| KNAQIGIAMLVSVGN | 726 | P08514 | |
| LIGQGQLNQAMKILQ | 186 | O76094 | |
| KVVQIVEIMQQGSQL | 746 | Q9UBF8 | |
| LLGQMQLQKGVVAVN | 526 | Q96J65 | |
| MLEGFQILVQNTVQG | 1 | Q58G82 | |
| LQMVTQGLVIGQLSS | 286 | Q96BI1 | |
| LNMLIKIIGNSVGAL | 876 | P35498 | |
| AIMGIQGEIQKICQT | 581 | Q08043 | |
| MKIAVIGQSLFGQEV | 1 | O75891 | |
| QALVIRGGEKMQINV | 176 | Q13733 | |
| RGGEKMQINVQEVVL | 181 | Q13733 | |
| IQRIVGVLQKPQMGE | 161 | Q8N365 | |
| INKGGIDAVESLMIN | 516 | Q8NHS4 | |
| AKQVTMAELNAIIGQ | 111 | Q04724 | |
| GENEQEKKMQIVLQG | 206 | P52747 | |
| ISMPQELQVLVKVNG | 91 | P0CG00 | |
| GTENIVAVMISNLKG | 146 | Q8N7C7 | |
| QKLFGMIITIGQSIV | 116 | P61619 | |
| LLEGNVVNGTIGKQM | 3881 | Q15413 | |
| VVNGTIGKQMVDTLV | 3886 | Q15413 | |
| TTMGVVAGILVQNVL | 256 | Q9GZZ9 | |
| LKFIQQMAGSVVVQL | 171 | Q9BSA4 | |
| MPQELQVLVKVNGVQ | 96 | A6NJL1 | |
| PNLGLVQMEKTINQV | 1031 | Q86TI0 | |
| QMLKTIGLEQIQAQG | 351 | A2RTY3 | |
| TLNMLIKIIGNSVGA | 866 | Q99250 | |
| VLMNGTLKQVLLVGA | 656 | P80108 | |
| GGKMSDILLQASVQV | 336 | Q9NRS4 | |
| AEIAGLQIGDKIMQV | 66 | O14907 | |
| LNMLIKIIGNSVGAL | 861 | Q9UQD0 | |
| DGEMNNLQISVIRIK | 991 | Q9UQD0 | |
| KQLAIQVSNILGMDV | 246 | Q9ULI2 | |
| IISRQKQMGQEIGNE | 161 | Q9UNK0 | |
| QLENIQKTGQEMIEG | 636 | P02549 | |
| LQSQVQTVLVRMGGL | 261 | A0PJX8 | |
| LIESMQINGSVLKNG | 781 | P22102 | |
| AKQVTMTELNAIIGQ | 111 | Q04726 | |
| MLVAEQAVGAGQLQV | 106 | Q96MT0 | |
| ELRKELIGQVMNQLG | 816 | Q9Y5L0 | |
| GDVVLKINGTVTENM | 226 | Q07157 | |
| IMENAEINNIIKIVG | 501 | P11388 | |
| GQITVKIMDNGIQGE | 276 | Q9C0B5 | |
| TIDQILEMVNGQRGL | 1221 | Q96AY4 | |
| GGIAQIIAAQEEMLK | 2496 | Q9Y4G6 | |
| DIEGILQKFTGNIMQ | 181 | Q8WWH5 | |
| KLSQMDQVIQGLVER | 251 | Q8TEQ8 | |
| MANINLKEITLIVGV | 1 | Q6ZXV5 | |
| LQQLLVGQEIGFTMD | 1701 | Q68DK2 | |
| QIQALMDEVTKQGNI | 841 | P56192 | |
| QVVQGMKEAQERLTG | 146 | O95881 | |
| TKFLELIGIAQGQMT | 1106 | P29597 | |
| IQKEVMNGAILQQVF | 116 | Q96D46 |